Log in

Guided Therapeutics Stock Price, News & Analysis (OTCBB:GTHP)

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume1.04 million shs
Average Volume18.71 million shs
Market Capitalization$430,000.00
P/E RatioN/A
Dividend YieldN/A
Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. The company focuses on marketing LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was founded in 1992 and is based in Norcross, Georgia.

Industry, Sector and Symbol

Industry Electromedical equipment
Current SymbolOTCBB:GTHP



Sales & Book Value

Annual Sales$240,000.00
Book Value($0.41) per share


Net Income$-10,690,000.00
Net Margins-2,779.03%


Outstanding Shares2,135,440,000
Market Cap$430,000.00
Next Earnings Date11/12/2019 (Estimated)
OptionableNot Optionable

Receive GTHP News and Ratings via Email

Sign-up to receive the latest news and ratings for GTHP and its competitors with MarketBeat's FREE daily newsletter.

Guided Therapeutics (OTCBB:GTHP) Frequently Asked Questions

What is Guided Therapeutics' stock symbol?

Guided Therapeutics trades on the OTCBB under the ticker symbol "GTHP."

How were Guided Therapeutics' earnings last quarter?

Guided Therapeutics Inc (OTCBB:GTHP) issued its quarterly earnings results on Monday, May, 21st. The medical technology company reported $0.00 EPS for the quarter. View Guided Therapeutics' Earnings History.

When is Guided Therapeutics' next earnings date?

Guided Therapeutics is scheduled to release their next quarterly earnings announcement on Tuesday, November 12th 2019. View Earnings Estimates for Guided Therapeutics.

Has Guided Therapeutics been receiving favorable news coverage?

Headlines about GTHP stock have been trending somewhat positive on Saturday, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Guided Therapeutics earned a coverage optimism score of 0.8 on InfoTrie's scale. They also gave news stories about the medical technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Guided Therapeutics.

Who are some of Guided Therapeutics' key competitors?

What other stocks do shareholders of Guided Therapeutics own?

Who are Guided Therapeutics' key executives?

Guided Therapeutics' management team includes the folowing people:
  • Mr. Gene S. Cartwright Ph.D., Chief Exec. Officer, Pres, Acting Chief Financial Officer and Director (Age 64)
  • Dr. Mark L. Faupel, COO & Director (Age 63)
  • Mr. Richard L. Fowler, Sr. VP of Engineering and Sec. (Age 62)
  • Mr. Charles Rufai, Controller

How do I buy shares of Guided Therapeutics?

Shares of GTHP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

How big of a company is Guided Therapeutics?

Guided Therapeutics has a market capitalization of $0.00 and generates $240,000.00 in revenue each year. View Additional Information About Guided Therapeutics.

What is Guided Therapeutics' official website?

The official website for Guided Therapeutics is http://www.guidedinc.com/.

How can I contact Guided Therapeutics?

Guided Therapeutics' mailing address is 5835 PEACHTREE CORNERS EAST SUITE D, NORCROSS GA, 30092. The medical technology company can be reached via phone at 770-242-8723 or via email at [email protected]

MarketBeat Community Rating for Guided Therapeutics (OTCBB GTHP)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  53 (Vote Outperform)
Underperform Votes:  60 (Vote Underperform)
Total Votes:  113
MarketBeat's community ratings are surveys of what our community members think about Guided Therapeutics and other stocks. Vote "Outperform" if you believe GTHP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GTHP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Featured Article: Intrinsic Value

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel